Nonfusion Alternative To Artificial Discs Acquired By Abbott/Spinal Concepts

Abbott Labs will launch a clinical trial early next year supporting a PMA submission for Spine Next's Wallis nonfusion spine stabilization device, having acquired the French manufacturer for $60 mil. and potential milestone payments

More from Archive

More from Medtech Insight